This is a Validated Antibody Database (VAD) review about pig transforming growth factor beta 1, based on 3 published articles (read how Labome selects the articles), using transforming growth factor beta 1 antibody in all methods. It is aimed to help Labome visitors find the most suited transforming growth factor beta 1 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
transforming growth factor beta 1 synonym: TGF-BETA-1; transforming growth factor beta-1; transforming growth factor, beta 1 (Camurati-Engelmann disease)

Invitrogen
chicken polyclonal
  • immunohistochemistry - paraffin section; rat; fig 5
In order to study the attenuation of bleomycin-induced pulmonary fibrosis in rats by aliskiren by focusing on advanced glycation end products, oxidative stress, and matrix metalloproteinease-9, Invitrogen transforming growth factor beta 1 antibody (Thermo Fisher Scientific, PA1-9574) was used in immunohistochemistry - paraffin section on rat samples (fig 5). Naunyn Schmiedebergs Arch Pharmacol (2016) ncbi
rabbit monoclonal (F.888.7)
  • western blot; human
In order to describe a new in vitro model to test the effect of an aligned fibrous environment on cancer cell morphology and behavior, Invitrogen transforming growth factor beta 1 antibody (Pierce Biotechnology, MA5-15065) was used in western blot on human samples . Acta Biomater (2014) ncbi
Abcam
mouse monoclonal (TB21)
  • western blot; mouse; 1:500; fig 4
Abcam transforming growth factor beta 1 antibody (Abcam, ab190503) was used in western blot on mouse samples at 1:500 (fig 4). Int J Mol Med (2016) ncbi
Articles Reviewed
  1. Hou C, Wu Q, Ouyang C, Huang T. Effects of an intravitreal injection of interleukin-35-expressing plasmid on pro-inflammatory and anti-inflammatory cytokines. Int J Mol Med. 2016;38:713-20 pubmed publisher
  2. Abuelezz S, Hendawy N, Osman W. Aliskiren attenuates bleomycin-induced pulmonary fibrosis in rats: focus on oxidative stress, advanced glycation end products, and matrix metalloproteinase-9. Naunyn Schmiedebergs Arch Pharmacol. 2016;389:897-909 pubmed publisher
  3. McLane J, Rivet C, Gilbert R, Ligon L. A biomaterial model of tumor stromal microenvironment promotes mesenchymal morphology but not epithelial to mesenchymal transition in epithelial cells. Acta Biomater. 2014;10:4811-4821 pubmed publisher